Content about Alzheimer's disease

April 4, 2013
Dementia costs more to treat than heart disease or cancer, study finds

The annual cost of treating dementia in the United States ranges from $157 billion to $215 billion, according to a new study by the RAND Corp.

March 12, 2013
Actavis seeks approval for Alzheimer's patch

Actavis is challenging Novartis' patent on a patch used to treat Alzheimer's disease, Actavis said.

December 3, 2012
Merck starts Alzheimer's drug trial

Merck has started a clinical trial that it hopes will eventually enroll 1,700 patients to evaluate an experimental drug for Alzheimer's disease, the company said.

July 24, 2012
Pfizer, J&J drug appears ineffective in some Alzheimer's patients

An experimental drug under development by Pfizer and a unit of Johnson & Johnson does not appear effective in Alzheimer's disease patients who carry a certain genotype, according to results of a late-stage clinical trial announced by Pfizer on Tuesday.

April 6, 2012
Sam's Club offers screenings for brain health

Sam's Club is offering free screenings for brain health at all of its stores that operate pharmacies this month, the retailer said Friday.

January 26, 2012
Pfizer, J&J subsidiary, charity group launch Alzheimer's Challenge 2012

Pfizer is partnering with a division of Johnson & Johnson and a charity organization to launch an initiative to award funding to projects designed to improve the diagnostic identification and tracking of Alzheimer's disease.

January 17, 2012
Pfizer, Medivation to discontinue Dimebon development following late-stage trial results

A late-stage clinical trial to evaluate a drug in Alzheimer's disease patients came up short, the drug's developers said Tuesday.

December 23, 2011
Bristol-Myers Squibb, Gladstone Institutes to collaborate on Alzheimer's drug discovery

Drug maker Bristol-Myers Squibb and the Gladstone Institutes will collaborate to find new ways to treat Alzheimer's disease, the two said Thursday.

November 15, 2011
Cara Inc. founder Ken O'Leary passes away

Kenneth O’Leary, president and founder of Cara Inc., passed away Oct. 12 at home after a long struggle with Alzheimer’s disease.

September 22, 2011
Dr. Reddy's launches generic Alzheimer's drug

Dr. Reddy's Labs has launched a drug for treating Alzheimer's disease, the company said.

June 7, 2011
Mylan subsidiary gets OK for generic Aricept

Another generic drug maker has been given the green light to market its version of an Alzheimer's disease treatment.

June 2, 2011
Teva's generic Aricept OKed by FDA

The Food and Drug Administration has approved a generic drug for Alzheimer’s disease made by Teva Pharmaceutical Industries.

June 1, 2011
Actavis' generic Aricept gets FDA nod

The Food and Drug Administration has approved a generic treatment for Alzheimer’s disease made by Actavis, the drug maker said Tuesday.

June 1, 2011
Sandoz gets green light for two generic Alzheimer's disease drugs

Sandoz has launched generic versions of treatments for Alzheimer’s disease, the generic pharmaceuticals division of Swiss drug maker Novartis said Wednesday.

April 11, 2011
Pfizer, Medivation 'disappointed' in phase-3 trial results for Dimebon

A drug originally developed by scientists in the Soviet Union to treat allergies and currently under investigation by Pfizer and Medivation did not yield significant results in a late-stage clinical trial of patients with Huntington disease, a disorder that leads to cognitive decline, the companies said Monday.

January 17, 2011
Takeda, Zinfandel form partnership

Japanese drug maker Takeda Pharmaceutical has signed an agreement with Durham, N.C.-based Zinfandel Pharmaceuticals to develop a test for assessing Alzheimer’s disease risk in adults, the two companies said.

January 5, 2011
Researchers find link between heart attacks, Alzheimer’s

BOLOGNA, Italy — Data from a new study by scientists in Italy could help physicians calculate patients’ risks for Alzheimer’s disease and heart attacks. Researchers at the University of Bologna said they found a common genetic link between heart attacks and Alzheimer’s, according to results of a study published in the Journal of Alzheimer’s Disease.


November 7, 2010
DHA supplements may help boost memory, study finds

According to a study published in the November edition of Alzheimer’s & Dementia: The Journal...

November 7, 2010
Lilly to acquire Avid

Eli Lilly's acquisition of a leader in molecular imaging development could boost its Alzheimer's disease...

November 3, 2010
PhRMA: Alzheimer’s drug market continues to expand

Nearly 100 drugs are in development for treating Alzheimer’s disease, according to a new report...

October 3, 2010
ProteoTech, Tasly Pharmaceuticals to develop Alzheimer’s drug

Privately owned drug-development company ProteoTech will work with a Chinese company to develop a drug...

September 26, 2010
Nestle to set up division to address health issues

Nestle will set up a health-and-wellness division to address such problems as obesity, cardiovascular disease,...

September 16, 2010
FDA accepts NDA for Aricept patch

The Food and Drug Administration has accepted for review a regulatory approval application for a...

September 9, 2010
Type 2 diabetes linked with cognitive impairments, study shows

A small study conducted by Canadian researchers found factors that may link Type 2 diabetes...

September 7, 2010
Greenstone, Eisai to launch authorized generic of Aricept

The generics division of Pfizer will sell an authorized generic version of a drug used...

© 2013 Drug Store News. All Rights Reserved.